Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 5
Abstract
Background and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV) coinfected patients are scarce. We assessed frequencies ofNS3 RAVs in patients infected with HCV genotype 1a with or without HIV coinfection. Material and methods. HCV NS3 amino acids 1-181 were sequenced by the Sanger method and analyzed for RAVs. RAVs and their distribution between HCV genotype 1a clade I and II viruses were compared between HIV-infected versus HIV-uninfected patients. Results. 148 samples were available (n = 68 HIV and n = 80 non-HIV). Relative frequency of clade I and clade II was significantly different between HIV (85% and 15%) and non-HIV groups (49% and 51%). Overall, HIV infected patients exhibited significantly lower prevalence of RAVs than HIV-uninfected patients (62% vs. 79%, p = 0.03). However, Q80K prevalence was significantly higher in HIV-infected subjects (50% vs. 24%, p = 0.001), whereas prevalence of S122D/G/N/S (2% vs. 16%, p = 0.002) and N174G/N/S (10% vs. 55%, p < 0.0001) polymorphisms were significantly lower. Q80K was found exclusively in clade I viruses. S122 (3% vs. 22%, p=0.001) and N174 (13% vs. 75%, p<0.0001) polymorphisms had significantly lower prevalence in clade I than clade II viruses. Conclusions. In the Netherlands, prevalence of clade I viruses and Q80K was significantly higher in HCV genotype 1a infected patients with HIV coinfection than in those without HIV coinfection. Prevalence of N174 and S122 polymorphisms was significantly higher in clade II than clade I viruses.
Authors and Affiliations
Faydra Lieveld, Niels Swaans, Astrid Newsum, Cynthia Ho, Janke Schinkel, Richard Molenkamp, Jan van der Meer, Joop Arends, Andy Hoepelman, Anne Wensing, Peter Siersema, Karel van Erpecum, Greet Boland
Keywords
Related Articles
- EP ID EP78614
- DOI 10.5604/16652681.1212426
- Views 128
- Downloads 0
Health-related quality of life in Egyptian patients after liver transplantation
Introduction-Aim. Health-Related Quality of Life (HRQOL) has become an important focus of patient care and clinical outcomes research with the improvement in patient and graft survival after liver transplantation (LT). T...
Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions
Background. Restrictive staging criteria for liver transplant (LT) patients with HCC in the U.S. have resulted in favorable long-term recurrence-free survival, but these criteria exclude a subgroup of patients who, despi...
Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico
Introduction. Hepatocellular carcinoma (HCC) has become a frequent type of cancer in Mexico. At the present time it represents the 19th cause of death in the population. Objective. To recognize the epidemiological profil...
Intrahepatic portal vein aneurysm in an asymptomatic patient
Hepatocellular carcinoma that arose from primary Sjögren’s syndrome
Hepatocellular carcinoma (HCC) typically originates from HBV or HCV associated liver cirrhosis. Primary Sjögren’s syndrome (pSS) is a kind of autoimmune disease. A sixty-two year old female patient with mild liver damage...